# Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps

> **NCT02285283** · PHASE2,PHASE3 · TERMINATED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 58 (actual)

## Conditions studied

- Chronic Rhinosinusitis

## Interventions

- **DRUG:** Itraconazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02285283
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-11
- **Primary completion:** 2019-05-15
- **Final completion:** 2019-05-15
- **Target enrollment:** 58 (ACTUAL)
- **Why stopped:** Recruitment failure.
- **Last updated:** 2020-10-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02285283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02285283, "Itraconazole for Fungal Sensitive Chronic Rhinosinusitis With Nasal Polyps". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02285283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*